Cardiol Therapeutics Inc
(TSX:CRDL)
C$
2.7
0 (0%)
Market Cap: 186.29 Mil
Enterprise Value: 157.89 Mil
PE Ratio: 0
PB Ratio: 9.18
GF Score: 33/100 Cardiol Therapeutics Inc (TSX:CRDL) Transcripts
- Cardiol Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Cardiol Therapeutics Inc at Canaccord Genuity Growth Conference TranscriptAug 10, 2023
- Cardiol Therapeutics Inc at Emerging Growth Conference TranscriptMay 25, 2022
- Cardiol Therapeutics Inc at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 29, 2021
- 1